IRMD
Iradimed Co
82.10$
-0.7%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +101.8% | +2.9% | -29.0% | +31.9% | +26.5% | -17.7% | +31.8% | +27.5% | +23.0% | +11.7% | +14.4% | |
| – | +71.6% | +5.4% | -9.5% | +29.5% | +22.2% | -7.6% | +19.9% | +23.1% | +28.1% | +9.7% | +15.4% | |
| – | +110.3% | +2.3% | -33.5% | +32.6% | +27.9% | -20.6% | +36.0% | +28.8% | +21.5% | +12.3% | +14.2% | |
| – | +65.1% | -23.6% | +27.8% | -11.9% | -5.6% | +32.8% | +0.1% | +19.6% | +25.5% | -0.9% | +5.1% | |
| – | +61.3% | +13.2% | +2.3% | -3.2% | +20.0% | +17.4% | -20.4% | +9.5% | +41.4% | +5.4% | +11.6% | |
| – | +55.1% | +8.3% | +5.2% | +6.1% | +22.2% | +15.6% | -8.6% | +15.4% | +17.4% | +14.1% | +11.0% | |
| – | +275.5% | -5.2% | -88.2% | +367.2% | +44.0% | -108.7% | – | +59.2% | +28.2% | +9.6% | +19.0% | |
| – | – | – | – | – | – | -64.8% | -86.6% | +3,027.4% | – | – | – | |
| – | +285.6% | -5.9% | -87.3% | +343.8% | +45.9% | -106.8% | – | +64.5% | +34.3% | +11.7% | +16.8% | |
| – | +324.5% | -8.9% | -76.0% | -111.8% | – | – | – | +556.5% | +35.6% | +10.9% | +16.7% | |
| – | +267.2% | -4.2% | -93.1% | +1,161.3% | +52.8% | -85.8% | +581.2% | +37.6% | +34.0% | +11.9% | +16.9% | |
| – | +258.1% | -3.0% | -76.8% | +174.1% | +39.1% | -94.1% | +1,829.4% | +45.0% | +22.9% | +25.2% | +22.5% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.